IN2014DN07839A - - Google Patents

Info

Publication number
IN2014DN07839A
IN2014DN07839A IN7839DEN2014A IN2014DN07839A IN 2014DN07839 A IN2014DN07839 A IN 2014DN07839A IN 7839DEN2014 A IN7839DEN2014 A IN 7839DEN2014A IN 2014DN07839 A IN2014DN07839 A IN 2014DN07839A
Authority
IN
India
Prior art keywords
intrauterine
formula
spirox
gynaecological
contraception
Prior art date
Application number
Other languages
English (en)
Inventor
Norbert Schmees
Lars Röse
Tuula Valo
Katja Prelle
Reinhard Nubbemeyer
Henriikka Korolainen
Harri Jukarainen
Original Assignee
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48142002&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2014DN07839(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Pharma AG filed Critical Bayer Pharma AG
Publication of IN2014DN07839A publication Critical patent/IN2014DN07839A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0039—Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IN7839DEN2014 2012-04-23 2013-04-19 IN2014DN07839A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102012206652 2012-04-23
PCT/EP2013/058220 WO2013160213A1 (de) 2012-04-23 2013-04-19 INTRAUTERINE ANWENDUNG VON 18-METHYL-15ß,16ß-METHYLEN-19-NOR-20-SPIROX-4-EN-3-ONEN, INTRAUTERINE SYSTEME ENTHALTEND 18-METHYL-15ß,16ß-METHYLEN-19-NOR-20-SPIROX-4-EN-3-ONE, SOWIE DEREN VERWENDUNG IN DER KONTRAZEPTION UND GYNÄKOLOGISCHEN THERAPIE

Publications (1)

Publication Number Publication Date
IN2014DN07839A true IN2014DN07839A (pt) 2015-04-24

Family

ID=48142002

Family Applications (1)

Application Number Title Priority Date Filing Date
IN7839DEN2014 IN2014DN07839A (pt) 2012-04-23 2013-04-19

Country Status (28)

Country Link
US (1) US20150065472A1 (pt)
EP (1) EP2841074A1 (pt)
JP (1) JP2015514791A (pt)
KR (1) KR20150004807A (pt)
CN (1) CN104254333A (pt)
AR (1) AR090799A1 (pt)
AU (1) AU2013254840A1 (pt)
BR (1) BR112014026193A2 (pt)
CA (1) CA2871003A1 (pt)
CL (1) CL2014002836A1 (pt)
CO (1) CO7111255A2 (pt)
CR (1) CR20140490A (pt)
CU (1) CU20140121A7 (pt)
DO (1) DOP2014000241A (pt)
EA (1) EA201491922A1 (pt)
EC (1) ECSP14024250A (pt)
HK (1) HK1205000A1 (pt)
IL (1) IL235095A0 (pt)
IN (1) IN2014DN07839A (pt)
MA (1) MA37444A1 (pt)
MX (1) MX2014012849A (pt)
PE (1) PE20142438A1 (pt)
PH (1) PH12014502372A1 (pt)
SG (1) SG11201406582XA (pt)
TN (1) TN2014000444A1 (pt)
TW (1) TW201350122A (pt)
UY (1) UY34758A (pt)
WO (1) WO2013160213A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015055789A1 (en) * 2013-10-17 2015-04-23 Bayer Pharma Aktiengesellschaft INTRAVAGINAL USE OF 18-METHYL-15ß,16ß-METHYLENE-19-NOR-20-SPIROX-4-EN-3-ONES, INTRAVAGINAL RINGS COMPRISING 18-METHYL-15ß,16ß-METHYLENE-19-NOR-20-SPIROX-4-EN-3-ONES, AND USE THEREOF IN CONTRACEPTION

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI90627C (fi) 1992-07-31 1994-03-10 Leiras Oy Laitteisto lääkeainesauvan varustamiseksi vaipalla
PH30867A (en) 1992-07-31 1997-12-09 Leiras Oy Method and equipment for installing a medicine capsule on a support.
FI107339B (fi) 1998-06-30 2001-07-13 Leiras Oy Lääkeaineiden läpäisynopeutta säätävä kalvo tai matriisi
US6056976A (en) 1998-11-12 2000-05-02 Leiras Oy Elastomer, its preparation and use
ATE442147T1 (de) * 2000-01-18 2009-09-15 Bayer Schering Pharma Ag Pharmazeutische zubereitung enthaltend drospirenon
WO2005007112A2 (en) * 2003-07-16 2005-01-27 Duramed Pharmaceuticals, Inc. Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
DE102006030416A1 (de) * 2006-06-29 2008-01-03 Bayer Schering Pharma Ag 18-Methyl-19-nor-androst-4-en-17,17-spiroether (18-Methyl-19-nor-20-spirox-4-en-3-one) sowie diese enthaltende pharmazeutische Präparate
DE102007011105A1 (de) * 2007-03-02 2008-09-04 Bayer Schering Pharma Aktiengesellschaft Mineralcorticoid-Rezeptor-Antagonisten zur Behandlung von Endometriose
DE102007063496A1 (de) * 2007-12-29 2009-07-02 Bayer Schering Pharma Aktiengesellschaft 15,16-Methylen-17-(1'-propenyl)-17-3'-oxidoestra-4-en-3-on-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007063495A1 (de) * 2007-12-29 2009-09-17 Bayer Schering Pharma Aktiengesellschaft 19-Nor-Steroidderivate mit einer 15α,16α-Methylengruppe und einem gesättigten 17,17-Spirolactonring, deren Verwendung sowie diese Derivate enthaltende Arzneimittel
EP2140860A1 (en) * 2008-07-03 2010-01-06 Bayer Schering Pharma Oy An improved method of contraception
PT2012063262W (pt) * 2010-11-08 2015-06-11 Hll Lifecare Ltd Um novo dispositivo intra-uterino com libertação controlada de cobre

Also Published As

Publication number Publication date
JP2015514791A (ja) 2015-05-21
IL235095A0 (en) 2014-12-31
CR20140490A (es) 2014-11-17
CL2014002836A1 (es) 2015-03-13
EA201491922A1 (ru) 2015-04-30
UY34758A (es) 2013-11-29
HK1205000A1 (en) 2015-12-11
SG11201406582XA (en) 2014-11-27
US20150065472A1 (en) 2015-03-05
DOP2014000241A (es) 2014-12-31
AU2013254840A1 (en) 2014-11-06
PH12014502372A1 (en) 2015-01-26
CU20140121A7 (es) 2014-12-26
CN104254333A (zh) 2014-12-31
TN2014000444A1 (en) 2016-03-30
AR090799A1 (es) 2014-12-10
BR112014026193A2 (pt) 2017-06-27
MA37444A1 (fr) 2016-11-30
KR20150004807A (ko) 2015-01-13
CO7111255A2 (es) 2014-11-10
MX2014012849A (es) 2015-02-05
CA2871003A1 (en) 2013-10-31
WO2013160213A1 (de) 2013-10-31
EP2841074A1 (de) 2015-03-04
PE20142438A1 (es) 2015-02-01
ECSP14024250A (es) 2015-12-31
TW201350122A (zh) 2013-12-16

Similar Documents

Publication Publication Date Title
IN2015DN01156A (pt)
PH12015501392A1 (en) Pesticidal compositions and processes related thereto
PH12014502397B1 (en) Pesticidal compositions and processes related thereto
EP4230264A3 (en) Prodrugs of fumarates and their use in treating various deseases
PH12015501394A1 (en) Pesticidal compositions and processes related thereto
PH12016501192A1 (en) Tetrahydropyridopyrazines modulators of gpr6
PH12015501393A1 (en) Pesticidal compositions and processes related thereto
PH12015502161A1 (en) Therapeutic compounds and compositions
PH12015501609A1 (en) Phenicol antibacterials
MX2015012414A (es) Sal de omecamtiv mecarbilo y proceso para preparar la sal.
PH12015501054A1 (en) Pyridiyloxyalkyl carboxamides and use thereof as endoparasiticides and nematicides
IN2015DN02109A (pt)
GEP201706636B (en) Galactagogue compositions based on phosphatidylserine
MX365192B (es) Derivados de bendamustina y compuestos relacionados, y uso medico de los mismos para la terapia de cancer.
IN2014DN07839A (pt)
MX2015014657A (es) Nuevos agentes antibacterianos de fenicol.
IN2014KN02584A (pt)
MX2017005669A (es) Derivados de hidroxido de bencilo, preparacion de los mismos y uso terapeutico de los mismos.
PH12014502371A1 (en) Application of 18-methyl-15ss,16ss-methylene-19-nor-20-spirox-4-en-3-one systems in the treatment of menorrhagia, as well as intrauterine systems containing 18-methyl-15ss,16ss-methylene-19-nor-20-spirox-4-en-3-one for treating uterine bleeding disorders
IN2012DE00937A (pt)
UA89388U (ru) Применение глюкозамина гидрохлорида как средства, защищающего организм от системного воздействия высоких температур
IN2013CH05171A (pt)
UA91886U (uk) 1-трет-бутокси-3-(2,2,6,6-тетраметил-4-гідроксипіперидино)-2-пропанол